Evidence map›Paper›PMID 36169218›Full record

ArticleCirculation research2022

A Single Nucleotide Polymorphism in

Matthew R Alexander, Samuel Hank, Bethany L Dale, Lauren Himmel, Xue Zhong, Charles D Smart, Daniel J Fehrenbach, Yuhan Chen, Nitin Prabakaran, Brian Tirado and 6 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Circulation research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The genetics of hypertension.Nature reviews. Nephrology · 2026
    Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Urinary βJournal of xenobiotics · 2025
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 3 countries.

Matthew R AlexanderDivision of Clinical Pharmacology (M.R.A., S.H., D.J.F., M.C., M.A., M.S.M.), Vanderbilt University Medical Center, Nashville, TN.
Samuel HankDivision of Clinical Pharmacology (M.R.A., S.H., D.J.F., M.C., M.A., M.S.M.), Vanderbilt University Medical Center, Nashville, TN.
Bethany L DaleDepartment of Cardiology, Drum Tower Hospital, Nanjing University Medical School, Jiangsu, China (Y.C.).
Lauren HimmelDepartment of Medicine, Department of Pathology, Microbiology, and Immunology (L.H.), Vanderbilt University Medical Center, Nashville, TN.
Xue ZhongDivision of Genetic Medicine (X.Z.), Vanderbilt University Medical Center, Nashville, TN.
Charles D SmartDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN (M.R.A., B.L.D., C.D.S., Y.C., M.S.M.).
Daniel J FehrenbachDivision of Clinical Pharmacology (M.R.A., S.H., D.J.F., M.C., M.A., M.S.M.), Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0003-3382-464X
Yuhan ChenDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN (M.R.A., B.L.D., C.D.S., Y.C., M.S.M.).
Nitin PrabakaranVanderbilt University, Nashville, TN (N.P., B.T.).
Brian TiradoVanderbilt University, Nashville, TN (N.P., B.T.).
Megan CentrellaDivision of Clinical Pharmacology (M.R.A., S.H., D.J.F., M.C., M.A., M.S.M.), Vanderbilt University Medical Center, Nashville, TN.
Mingfang AoDivision of Clinical Pharmacology (M.R.A., S.H., D.J.F., M.C., M.A., M.S.M.), Vanderbilt University Medical Center, Nashville, TN.
Liping DuDepartment of Biostatistics (L.D., Y.S.), Vanderbilt University Medical Center, Nashville, TN.
Yu ShyrDepartment of Biostatistics (L.D., Y.S.), Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0003-2086-9670
Daniel LevyFramingham Heart Study, Framingham, MA (D.L.).ORCID 0000-0003-1843-8724
Meena S MadhurDivision of Clinical Pharmacology (M.R.A., S.H., D.J.F., M.C., M.A., M.S.M.), Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0002-0407-634X
Vanderbilt University Medical Center · USVanderbilt University · USNanjing Drum Tower Hospital · CNNational Heart Lung and Blood Institute · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007347 · NIGMS · VANDERBILT UNIVERSITY · PI WILLIAMS, CHRISTOPHER S. · 1985 to 2023
$26.3M
Pharmacogenomics of Arrhythmia TherapyU19HL065962 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RODEN, DAN M · 2010 to 2014
$17.4M
Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
Understanding and preventing HLA-associated drug reactionsP50GM115305 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DENNY, JOSHUA C. · 2015 to 2019
$13.0M
The Genetic Epemiology of Multiple SclerosisR01NS032830 · NINDS · VANDERBILT UNIVERSITY · PI HAINES, JONATHAN L · 1995 to 2010
$8.9M
Epidemiologic Architecture for Genes Linked to Environment (EAGLE)U01HG004798 · NHGRI · VANDERBILT UNIVERSITY · PI CRAWFORD, DANA C · 2008 to 2013
$8.8M
Training In Cardiovascular ResearchT32HL007411 · NHLBI · VANDERBILT UNIVERSITY · PI BECKMAN, JOSHUA A · 1985 to 2020
$7.2M
NCATS NIH HHS UL1 TR000445NCATS NIH HHS UL1 TR002243NCI NIH HHS P30 CA068485NCRR NIH HHS S10 RR025141NCRR NIH HHS UL1 RR024975NHGRI NIH HHS U01 HG004798NHGRI NIH HHS U01 HG006378NHGRI NIH HHS U01 HG009086NHLBI NIH HHS DP2 HL137166NHLBI NIH HHS F30 HL151069NHLBI NIH HHS F32 HL144048NHLBI NIH HHS K08 HL153786NHLBI NIH HHS R01 HL161212NHLBI NIH HHS T32 HL007411NHLBI NIH HHS U19 HL065962NICHD NIH HHS R01 HD074711NIDDK NIH HHS P30 DK020593NIDDK NIH HHS U24 DK059637NIGMS NIH HHS P50 GM115305NIGMS NIH HHS RC2 GM092618NIGMS NIH HHS T32 GM007347NIGMS NIH HHS T32 GM152284NIH HHS S10 OD017985NIH HHS S10 OD023475NINDS NIH HHS R01 NS032830
6 · The paper itself

Abstract

backgroundSH2B3 (SH2B adaptor protein 3) is an adaptor protein that negatively regulates cytokine signaling and cell proliferation. A common missense single nucleotide polymorphism in

methodsWe used CRISPR-Cas9 technology to create mice homozygous for the major (Arg/Arg) and minor (Trp/Trp) alleles of this

resultsTrp/Trp mice exhibit 10 mmHg higher systolic BP during chronic Ang II infusion compared to Arg/Arg controls. Renal injury and perivascular fibrosis are exacerbated in Trp/Trp mice compared to Arg/Arg controls following Ang II infusion. Renal and ex vivo stimulated splenic CD8

conclusionsTaken together, these results suggest that the Trp encoding allele of rs3184504 is causal for BP elevation and renal dysfunction, in part through loss of SH2B3-mediated repression of T cell IL-12 signaling leading to enhanced IFNg production.

Indexed as

HypertensionHypertension, RenalAdaptor Proteins, Signal TransducingAngiotensin IIAnimalsArginineCD8-Positive T-LymphocytesFibrosisGenome-Wide Association StudyHumansInterferon-gammaInterleukin-12KidneyMiceMice, Inbred C57BLMice, KnockoutAdaptor Proteins, Signal TransducingAngiotensin IIArginineInterferon-gammaInterleukin-12Lnk protein, mouseTryptophancytokineshypertensioninflammationlymphocytespolymorphism, single nucleotide

Identifiers

PMID36169218
PMCPMC9588739
OpenAlexW4297461880

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.